Related Experiment Video

Updated: May 29, 2026

CAM-Delam Assay to Score Metastatic Properties by Quantifying Delamination and Invasion Capacity of Cancer Cells
12:14

CAM-Delam Assay to Score Metastatic Properties by Quantifying Delamination and Invasion Capacity of Cancer Cells

Published on: June 2, 2022

Dissecting the diverse functions of the metastasis suppressor CD82/KAI1

Yien Che Tsai1, Allan M Weissman

  • 1Laboratory of Protein Dynamics and Signaling, Center for Cancer Research, National Cancer Institute, Frederick, MD 21702, United States. tsaiyien@mail.nih.gov

FEBS Letters
|August 31, 2011
PubMed

Insights

Metastasis suppressor CD82/KAI1 inhibits cancer spread by regulating cell movement and organization. This protein impacts cell polarity, senescence, and apoptosis, crucial for controlling malignant progression.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Metastasis, the spread of cancer, is a key hallmark of malignancy.
  • Metastasis suppressor genes inhibit cancer spread without affecting primary tumor growth.
  • CD82/KAI1 is a metastasis suppressor belonging to the tetraspanin superfamily.

Purpose of the Study:

  • To elucidate the mechanisms by which CD82 suppresses metastasis.
  • To understand the role of CD82 in regulating cellular processes relevant to cancer progression.

Main Methods:

  • Investigated CD82's function in inhibiting cell motility and invasion.
  • Examined CD82's role in promoting cell polarity.
  • Studied CD82's induction of senescence and apoptosis.
  • Analyzed CD82's regulation of membrane organization, protein trafficking, and interactions.

Main Results:

  • CD82/KAI1 effectively suppresses metastasis through various mechanisms.
  • CD82 inhibits cancer cell motility and invasion, key steps in metastasis.
  • CD82 promotes cell polarity and induces apoptosis and senescence.
  • CD82 influences cellular signaling and communication by regulating membrane organization and protein trafficking.

Conclusions:

  • CD82/KAI1 is a critical metastasis suppressor with diverse inhibitory functions.
  • CD82's regulation of cellular processes and interactions is central to its anti-metastatic activity.
  • Understanding CD82's mechanisms offers potential therapeutic strategies against cancer metastasis.

More Related Videos

The Establishment of a Lung Colonization Assay for Circulating Tumor Cell Visualization in Lung Tissues07:39

The Establishment of a Lung Colonization Assay for Circulating Tumor Cell Visualization in Lung Tissues

Published on: June 16, 2018

Related Concept Videos

Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However, invadopodia can...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...